Skip to main content
. 2018 Mar 1;2018:8512745. doi: 10.1155/2018/8512745

Figure 5.

Figure 5

Western blot showed that the expression of Beclin-1 and LC3-II decreased and p62 increased in the NP cells when treated with PPARγ antagonist. # represents a significant difference from 0.2 M high glucose condition (p < .05).